Epigenetics Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017 - 2025
Global Epigenetics Market: Overview
The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market. Epigenetic changes are extensively used in cancer research for studying tumor biology as well as to develop therapeutic drugs to fight cancer.
Global Epigenetics Market: Trends
The recent market trend of increasingly using epigenetics for understanding the development of a disease extensively fuel the growth of this market in the coming years. Another trend that will aid the growth of the global epigenetics market is the escalating demand for personalized medicine. Extensive investments are being made by various organisations, pharmaceutical companies, and governments for the research and development of drugs, and this is another trend that is benefiting the growth of the global epigenetics market. This is because epigenetic techniques enable researchers to compare epigenetic changes between disease samples and normal samples. Public health can thus be analyzed as the changes in epigenetics are influenced by internal biological system and environment directly.
With the economies of developing countries growing faster than that of developed countries, several institutes and research facilities are being set up in the developing countries. The rise in the number of testing and research facilities, particularly in the field of biotechnology and pharmaceuticals, will lead to a rise in demand for epigenetic analysis for diagnosis of diseases and development of therapeutic drugs. This will also drive the growth prospects of the global epienetics market.
Global Epigenetics Market: Market Potential
The rise in the application of epigenetics for cancer prevention as well as cancer diagnosis thanks to technologies such as epigenetics therapy and DNA methylation to control cancer or diagnose cancer respectively, will create new opportunities of growth in the global epigenetics market. New methods such as such as ChIP and next generation sequencing (NGS) are being used to understand gene sequence which are modified due to epigenetic changes. The growing number of retail clinics, companion diagnostics, and the development of whole genome technology are pushing the demand for personalized medicine. This is also acting as a driver for the global epienetics market. As different people react differently to a particular medicine, increasing number of patients and doctors are inclined towards personalized medicine.
Investments in research and development has increased remarkably in the last few years. As investments from the developing economies pricing faster then developed nation where is research facilities is an institution setup in developing companies which is giving rise to testing biotechnology thereby giving rise to a heightened demand for disease diagnosis and development of therapeutic drugs.
Global Epigenetics Market: Regional Outlook
The global epigenetics market is segmented on the basis of geography into Asia Pacific, North America, Europe, and the Rest of the World. Of these, North America has been leading in this market in account of the early adoption of advanced technologies and solutions. Increased investments in research and development as well as growing geriatric population, and the increasing pool patient population are some of the other factors which make North America a key market for epigenetics. In addition to North America, it is estimated the developing economies in Asia Pacific will emerge as lucrative markets for epigenetics.
Global Epigenetics Market: Competitive Landscape
Illumina, Diagenode, Abcam, CellCentric Ltd, Merck, Thermo Fisher Scientific, Zymo research, Qiagen, Chroma Therapeutics Ltd,Syndax Pharmaceuticals, Inc., Sigma-Aldrich Corporation, Eisai Co. Ltd, Oncolys Biopharma Inc., Novartis International AG, and Valirx Plc are some of the leading players within the global epienetics market.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report